Robin A. Raymer
Impact in
- Hematology top 5%
- Hemophilia Treatment and Research
- Platelet Disorders and Treatments
- Blood Coagulation and Thrombosis Mechanisms
- Hemostasis and retained surgical items
- Genetics top 10%
- Virus-based gene therapy research
Papers in
- Hematology 17
- Platelet Disorders and Treatments 14
- Hemophilia Treatment and Research 11
- Blood Coagulation and Thrombosis Mechanisms 4
- Blood groups and transfusion 3
-
- Cancer-related gene regulation 3
- Co-authors
- Timothy C. Nichols (22 shared papers)Elizabeth P. Merricks (23 shared papers)Dwight A. Bellinger (11 shared papers)Thomas Fischer (4 shared papers)Marjorie S. Read (4 shared papers)Lingfei Xu (1 shared paper)Shirong Cai (1 shared paper)Katherine P. Ponder (1 shared paper)
- Journals
- Blood (5 papers)British Journal of Haematology (2 papers)PLoS ONE (2 papers)Journal of Pharmaceutical Sciences (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesDenmarkFrance
In The Last Decade
Robin A. Raymer
24 papers receiving 534 citations
Peers
Comparison fields: 5 of 67
- Hematology 269
- Genetics 207
- Critical Care and Intensive Care Medicine 32
- Biochemistry 35
- Oncology 131
Countries citing papers authored by Robin A. Raymer
This map shows the geographic impact of Robin A. Raymer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin A. Raymer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin A. Raymer more than expected).
Fields of papers citing papers by Robin A. Raymer
This network shows the impact of papers produced by Robin A. Raymer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin A. Raymer. The network helps show where Robin A. Raymer may publish in the future.
Co-authors
The 25 scholars most cited alongside Robin A. Raymer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 93 | |
| 2 | 2003 | 82 | |
| 3 | 2017 | 54 | |
| 4 | 2003 | 34 | |
| 5 | 2003 | 34 | |
| 6 | 2016 | 30 | |
| 7 | 2018 | 27 | |
| 8 | 2000 | 24 | |
| 9 | 2001 | 22 | |
| 10 | 2010 | 22 | |
| 11 | 2010 | 20 | |
| 12 | 2015 | 18 | |
| 13 | 2000 | 14 | |
| 14 | 2014 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2011 | 10 | |
| 17 | 2011 | 9 | |
| 18 | 2015 | 8 | |
| 19 | 2015 | 6 | |
| 20 | 2017 | 5 |
About Robin A. Raymer
Robin A. Raymer is a scholar working on Hematology, Molecular Biology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 24 papers that have together received 547 indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (14 papers), Hemophilia Treatment and Research (11 papers), Virus-based gene therapy research (5 papers), Blood properties and coagulation (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Blood groups and transfusion (3 papers), Cancer-related gene regulation (3 papers) and Ultrasound Imaging and Elastography (2 papers). The work is most often cited by research in Hematology (269 citations), Genetics (207 citations), Critical Care and Intensive Care Medicine (32 citations), Biochemistry (35 citations) and Oncology (131 citations). Robin A. Raymer has collaborated with scholars based in United States, Denmark and France. Frequent co-authors include Timothy C. Nichols, Elizabeth P. Merricks, Dwight A. Bellinger, Thomas Fischer, Marjorie S. Read, Lingfei Xu, Shirong Cai, Katherine P. Ponder, Cuihua Gao and Mark S. Sands. Their work appears in journals such as Blood, British Journal of Haematology, PLoS ONE, Journal of Pharmaceutical Sciences and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.